NCT07288905Recruiting
Exploring the Effects of Exercise Combined With BFRT on Healthy and Patients With CKD
The Feasibility and Effects of Exercise Training Combined With Blood Flow Restriction Training on Exercise Capacity and Exercise Tolerance in Patients With Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 17 Dec 2025
Brief summary (registry, in English)
Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in healthy and CKD patients
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 16 Nov 2025
- Start date
- 4 Oct 2025
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- National Cheng Kung University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07288905
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 4 Oct 2025 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe uncontrolled metabolic diseases (e.g., hyperthyroidism, diabetes, hypertension, hyperlipidemia, etc.)
- Severe pulmonary or cardiovascular diseases (e.g., pulmonary hypertension, chronic obstructive pulmonary disease (COPD), heart failure, cardiac arrhythmia)
- Presence of a cardiac pacemaker or a history of myocardial infarction within the past six months
- Severe musculoskeletal or neuromuscular disorders (e.g., advanced arthritis, limb amputation, post-polio syndrome, Parkinson's disease)
- Unstable vital signs (e.g., systolic blood pressure ≥180 mmHg, diastolic blood pressure ≥90 mmHg, requiring vasopressors, or resting heart rate \>100 bpm)
- Kidney function impairment
- Cancer
- Severe uncontrolled metabolic diseases (e.g., hyperthyroidism, diabetes, hypertension, hyperlipidemia, etc.)
- Severe pulmonary or cardiovascular diseases (e.g., pulmonary hypertension, chronic obstructive pulmonary disease (COPD), heart failure, cardiac arrhythmia)
- Presence of a cardiac pacemaker or a history of myocardial infarction within the past six months
- Severe musculoskeletal or neuromuscular disorders (e.g., advanced arthritis, limb amputation, post-polio syndrome, Parkinson's disease)
- Unstable vital signs (e.g., systolic blood pressure ≥180 mmHg, diastolic blood pressure ≥90 mmHg, requiring vasopressors, or resting heart rate \>100 bpm)
- Diagnosed systemic diseases under ongoing treatment (e.g., systemic lupus erythematosus, cancer, malignancies).
Lab values
- Abnormal blood biochemical parameters (e.g., white blood cell count \<2500/mm³, hemoglobin \<8 mg/dL, total bilirubin \>3 mg/dL, liver enzymes (GOT/AST, GPT/ALT) \>3 times the upper limit of normal, platelet count \<75,000/mm³
Other
- Prone to bruising
- Recent inflection \< 1 month
- Pregnancy
- Simultaneously participating in other research
- CKD
- Sensory or motor dysfunctions that affect walking ability
Who the study is looking for
- Aged 20\~85 years old
- Aged 20\~85 years old
- eGFR\< 90 ml/min/1.73 m2 over 3 months
- Stable condition without worsening in the past 3 months
- Ability to understand and follow verbal commends and cooperate with an exercise training program
Criteria the registry did not label
- Healthy
Age in the registry: 20 years to 85 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Cheng Kung University Hospital Coordinator of this site? Confirm its status | Tainan | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.